AG0034OM

219311-44-1 | N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide

Chemical structure of N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide, CAS 219311-44-1
AG0034OM
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 219311-44-1
Catalog Number AG0034OM(AGN-PC-0JN7K9)
Chemical Name N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide
IUPAC Name N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide
InChI InChI=1S/C12H16ClN3O3S/c1-8-10(19-7-11-14-5-6-15-11)4-3-9(13)12(8)16-20(2,17)18/h3-4,16H,5-7H2,1-2H3,(H,14,15)
InChI Key FOYWMEJSRSBQGB-UHFFFAOYSA-N
MDL Number MFCD13195546
Molecular Formula C12H16ClN3O3S
Molecular Weight 317.7917
SMILES Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1
UNII LGX4GZ74WO
Synonyms
dabuzalgron, dabuzalgron hydrochloride, Ro 115-1240, Ro-115-1240, Ro115-1240, Dabuzalgron, 219311-44-1, Ro-115-1240, N-(6-Chloro-3-((4,5-dihydro-1H-imidazol-2-yl)methoxy)-2-methylphenyl)methanesulfonamide, n-[6-chloro-3-(4,5-dihydro-1h-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide, UNII-LGX4GZ74WO, LGX4GZ74WO, CHEMBL257978, n-(6-chloro-3-((4,5-dihydro-1H-imidazol-2-yl)methoxy)-2-methyl phenyl)methanesulfonamide, Dabuzalgron [INN], Ro-1151240190, dabuzalgronum, AC1L50CX, AC1Q6W48, GTPL3469, SCHEMBL5203336, DTXSID50176345, CHEBI:142452, BDBM50377398, ZINC49952320, AKOS024257909, AN-29530, Ro 115-1240, TX-013450, R 450, 311D441, A1-01879, N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methyl-phenyl]methanesulfonamide, D0Z3UP, Alpha-1 adrenoceptor agonist, Roche, AR-1K4245, CID216249, R-450, 23892-50-4,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited